-
2
-
-
65549130606
-
The German version of the Chronic Urticaria Quality-of-Life Questionnaire: Factor analysis, validation, and initial clinical findings
-
Mlynek A, Magerl M, Hanna M, et al. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009; 64:927-936.
-
(2009)
Allergy
, vol.64
, pp. 927-936
-
-
Mlynek, A.1
Magerl, M.2
Hanna, M.3
-
3
-
-
70349210289
-
EAACI/GA(2)LEN/EDF/WAO guideline: Management of urticaria
-
Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64:1427-1443.
-
(2009)
Allergy
, vol.64
, pp. 1427-1443
-
-
Zuberbier, T.1
Asero, R.2
Bindslev-Jensen, C.3
-
4
-
-
70349214906
-
EAACI/GA(2)LEN/EDF/WAO guideline: Definition, classification and diagnosis of urticaria
-
Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64:1417-1426.
-
(2009)
Allergy
, vol.64
, pp. 1417-1426
-
-
Zuberbier, T.1
Asero, R.2
Bindslev-Jensen, C.3
-
5
-
-
84864202434
-
Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common moulds
-
Staubach P, Vonend A, Burow G, et al.. Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common moulds. Mycoses 2008.
-
(2008)
Mycoses
-
-
Staubach, P.1
Vonend, A.2
Burow, G.3
-
6
-
-
0017367289
-
Solar urticaria. Photoallergen in a patient's serum
-
DOI 10.1001/archderm.113.2.157
-
Horio T, Minami K. Solar uticaria. Photoallergen in a patients serum. Arch Dermatol 1977; 113:157-160. (Pubitemid 8033151)
-
(1977)
Archives of Dermatology
, vol.113
, Issue.2
, pp. 157-160
-
-
Horio, T.1
Minami, K.2
-
7
-
-
0024240589
-
Cholinergic urticaria, passive transfer experiments from human to monkey
-
Murphy GM, Greaves MW, Zollman PE, Winkelmann RK. Cholinergic urticaria, passive transfer experiments from human to monkey. Dermatologica 1988; 177:338-340. (Pubitemid 19044327)
-
(1988)
Dermatologica
, vol.177
, Issue.6
, pp. 338-340
-
-
Murphy, G.M.1
Greaves, M.W.2
Zollman, P.E.3
Winkelmann, R.K.4
-
8
-
-
0023268805
-
Symptomatic dermographism (factitious urticaria) - passive transfer experiments from human to monkey
-
DOI 10.1111/j.1365-2133.1987.tb04898.x
-
Murphy GM, Zollman PE, Greaves MW, Winkelmann RK. Symptomatic dermographism (factitious urticaria): passive transfer experiments from human to monkey. Br J Dermatol 1987; 116:801-804. (Pubitemid 17075399)
-
(1987)
British Journal of Dermatology
, vol.116
, Issue.6
, pp. 801-804
-
-
Murphy, G.M.1
Zollman, P.E.2
Greaves, M.W.3
Winkelmann, R.K.4
-
9
-
-
79954462805
-
IgE mediated autoallergy against thyroid peroxidase: A novel pathomechanism of chronic spontaneous urticaria?
-
Altrichter S, Peter HJ, Pisarevskaja D, et al. IgE mediated autoallergy against thyroid peroxidase: a novel pathomechanism of chronic spontaneous urticaria? PLoS One 2011; 6:e14794.
-
(2011)
PLoS One
, vol.6
-
-
Altrichter, S.1
Peter, H.J.2
Pisarevskaja, D.3
-
10
-
-
80052299857
-
A randomized, placebo-controlled, doseranging study of single-dose omalizumab in patients with H1-antihistaminerefractory chronic idiopathic urticaria
-
Saini S, Rosen KE, Hsieh HJ, et al. A randomized, placebo-controlled, doseranging study of single-dose omalizumab in patients with H1-antihistaminerefractory chronic idiopathic urticaria. J Allergy Clin Immunol 2011; 128:567-573.
-
(2011)
J Allergy Clin Immunol
, vol.128
, pp. 567-573
-
-
Saini, S.1
Rosen, K.E.2
Hsieh, H.J.3
-
11
-
-
79959855552
-
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
-
e205
-
Maurer M, Altrichter S, Bieber T, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol 2011; 128:202e205-209e205.
-
(2011)
J Allergy Clin Immunol
, vol.128
, Issue.202
-
-
Maurer, M.1
Altrichter, S.2
Bieber, T.3
-
12
-
-
84859799340
-
Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey
-
Büyüköztürk S, Gelincik A, Demirturk M, et al. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey. J Dermatol 2012; 39:439-442.
-
(2012)
J Dermatol
, vol.39
, pp. 439-442
-
-
Büyüköztürk, S.1
Gelincik, A.2
Demirturk, M.3
-
13
-
-
80052872083
-
Omalizumab in treatment-resistant chronic spontaneous urticaria
-
Godse KV. Omalizumab in treatment-resistant chronic spontaneous urticaria. Indian J Dermatol 2011; 56:444.
-
(2011)
Indian J Dermatol
, vol.56
, pp. 444
-
-
Godse, K.V.1
-
14
-
-
79955575746
-
Omalizumab is effective in nonautoimmune urticaria
-
Ferrer M, Gamboa P, Sanz ML, et al. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol 2011; 127:1300-1302.
-
(2011)
J Allergy Clin Immunol
, vol.127
, pp. 1300-1302
-
-
Ferrer, M.1
Gamboa, P.2
Sanz, M.L.3
-
15
-
-
78651096597
-
Omalizumab: An effective and safe treatment of therapy-resistant chronic spontaneous urticaria
-
Groffik A, Mitzel-Kaoukhov H, Magerl M, et al. Omalizumab: an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy 2011; 66:303-305.
-
(2011)
Allergy
, vol.66
, pp. 303-305
-
-
Groffik, A.1
Mitzel-Kaoukhov, H.2
Magerl, M.3
-
16
-
-
78649383197
-
Omalizumab therapy in three patients with chronic autoimmune urticaria
-
Al-Ahmad M. Omalizumab therapy in three patients with chronic autoimmune urticaria. Ann Saudi Med 2010; 30:478-481.
-
(2010)
Ann Saudi Med
, vol.30
, pp. 478-481
-
-
Al-Ahmad, M.1
-
17
-
-
77956394970
-
Effective treatment of therapyresistant chronic spontaneous urticaria with omalizumab
-
Magerl M, Staubach P, Altrichter S, et al. Effective treatment of therapyresistant chronic spontaneous urticaria with omalizumab. J Allergy Clin Immunol 2010; 126:665-666.
-
(2010)
J Allergy Clin Immunol
, vol.126
, pp. 665-666
-
-
Magerl, M.1
Staubach, P.2
Altrichter, S.3
-
18
-
-
50649084564
-
Treatment of chronic autoimmune urticaria with omalizumab
-
Kaplan AP, Joseph K, Maykut RJ, et al. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008; 122:569-573.
-
(2008)
J Allergy Clin Immunol
, vol.122
, pp. 569-573
-
-
Kaplan, A.P.1
Joseph, K.2
Maykut, R.J.3
-
21
-
-
79960694270
-
T cell activity in successful treatment of chronic urticaria with omalizumab
-
Sánchez-Machin I, Iglesias-Souto J, Franco A, et al. T cell activity in successful treatment of chronic urticaria with omalizumab. Clin Mol Allergy 2011; 9:11.
-
(2011)
Clin Mol Allergy
, vol.9
, pp. 11
-
-
Sánchez-Machin, I.1
Iglesias-Souto, J.2
Franco, A.3
-
22
-
-
78651483333
-
Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab
-
Saavedra MC, Sur S. Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab. Clin Mol Allergy 2011; 9:2.
-
(2011)
Clin Mol Allergy
, vol.9
, pp. 2
-
-
Saavedra, M.C.1
Sur, S.2
-
23
-
-
79952276285
-
Omalizumab for therapy-resistant chronic urticaria with angioedema
-
Korkmaz H, Eigelshoven S, Homey B. Omalizumab for therapy-resistant chronic urticaria with angioedema. Hautarzt 2010; 61:828-831.
-
(2010)
Hautarzt
, vol.61
, pp. 828-831
-
-
Korkmaz, H.1
Eigelshoven, S.2
Homey, B.3
-
24
-
-
77954362538
-
Immunological effects of omalizumab in chronic urticaria: A case report
-
Iemoli E, Piconi S, Fusi A, et al. Immunological effects of omalizumab in chronic urticaria: a case report. J Investig Allergol Clin Immunol 2010; 20:252-254.
-
(2010)
J Investig Allergol Clin Immunol
, vol.20
, pp. 252-254
-
-
Iemoli, E.1
Piconi, S.2
Fusi, A.3
-
25
-
-
77954941791
-
Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab
-
Vestergaard C, Deleuran M. Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab. Acta Derm Venereol 2010; 90:443-444.
-
(2010)
Acta Derm Venereol
, vol.90
, pp. 443-444
-
-
Vestergaard, C.1
Deleuran, M.2
-
26
-
-
76749153779
-
Maintenance of remission with lowdose omalizumab in long-lasting, refractory chronic urticaria
-
Romano C, Sellitto A, De Fanis U, et al. Maintenance of remission with lowdose omalizumab in long-lasting, refractory chronic urticaria. Ann Allergy Asthma Immunol 2010; 104:95-97.
-
(2010)
Ann Allergy Asthma Immunol
, vol.104
, pp. 95-97
-
-
Romano, C.1
Sellitto, A.2
De Fanis, U.3
-
28
-
-
0016812740
-
In vivo studies of mediator release in cold urticaria and cholinergic urticaria
-
Kaplan AP, Gray L, Shaff RE, et al. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol 1975; 55:394-402.
-
(1975)
J Allergy Clin Immunol
, vol.55
, pp. 394-402
-
-
Kaplan, A.P.1
Gray, L.2
Shaff, R.E.3
-
29
-
-
0015583068
-
Dermographia mediated by immunoglobulin e
-
Newcomb RW, Nelson H. Dermographia mediated by immunoglobulin E. Am J Med 1973; 54:174-180.
-
(1973)
Am J Med
, vol.54
, pp. 174-180
-
-
Newcomb, R.W.1
Nelson, H.2
-
31
-
-
33646947344
-
Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE
-
DOI 10.1016/j.jaci.2006.04.003, PII S0091674906008529
-
Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006; 117:1415-1418. (Pubitemid 43795744)
-
(2006)
Journal of Allergy and Clinical Immunology
, vol.117
, Issue.6
, pp. 1415-1418
-
-
Boyce, J.A.1
-
32
-
-
77956078962
-
Antiimmunoglobulin e treatment of patients with recalcitrant physical urticaria
-
Metz M, Altrichter S, Ardelean E, et al. Antiimmunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol 2011; 154:177-180.
-
(2011)
Int Arch Allergy Immunol
, vol.154
, pp. 177-180
-
-
Metz, M.1
Altrichter, S.2
Ardelean, E.3
-
33
-
-
81355154609
-
Failure of omalizumab (Xolair(R)) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light
-
Duchini G, Baumler W, Bircher AJ, Scherer K. Failure of omalizumab (Xolair(R)) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light. Photodermatol Photoimmunol Photomed 2011; 27:336-337.
-
(2011)
Photodermatol Photoimmunol Photomed
, vol.27
, pp. 336-337
-
-
Duchini, G.1
Baumler, W.2
Bircher, A.J.3
Scherer, K.4
-
34
-
-
78649260196
-
Antihistamine-resistant urticaria factitia successfully treated with antiimmunoglobulin e therapy
-
Krause K, Ardelean E, Kessler B, et al. Antihistamine-resistant urticaria factitia successfully treated with antiimmunoglobulin E therapy. Allergy 2010; 65:1494-1495.
-
(2010)
Allergy
, vol.65
, pp. 1494-1495
-
-
Krause, K.1
Ardelean, E.2
Kessler, B.3
-
36
-
-
77953111313
-
Effective treatment of refractory severe heat urticaria with omalizumab
-
Bullerkotte U, Wieczorek D, Kapp A, Wedi B. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy 2010; 65:931-932.
-
(2010)
Allergy
, vol.65
, pp. 931-932
-
-
Bullerkotte, U.1
Wieczorek, D.2
Kapp, A.3
Wedi, B.4
-
37
-
-
77951241500
-
Failure of omalizumab in cholinergic urticaria
-
Sabroe RA. Failure of omalizumab in cholinergic urticaria. Clin Exp Dermatol 2010; 35:e127-e129.
-
(2010)
Clin Exp Dermatol
, vol.35
-
-
Sabroe, R.A.1
-
38
-
-
72049102902
-
Efficacy of omalizumab in delayed pressure urticaria: A case report
-
Bindslev-Jensen C, Skov PS. Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy 2010; 65:138-139.
-
(2010)
Allergy
, vol.65
, pp. 138-139
-
-
Bindslev-Jensen, C.1
Skov, P.S.2
-
39
-
-
53749100152
-
Successful treatment of solar urticaria with antiimmunoglobulin e therapy
-
Güzelbey O, Ardelean E, Magerl M, et al. Successful treatment of solar urticaria with antiimmunoglobulin E therapy. Allergy 2008; 63:1563-1565.
-
(2008)
Allergy
, vol.63
, pp. 1563-1565
-
-
Güzelbey, O.1
Ardelean, E.2
Magerl, M.3
-
40
-
-
37749011236
-
Successful treatment of cholinergic urticaria with antiimmunoglobulin e therapy
-
Metz M, Bergmann P, Zuberbier T, Maurer M. Successful treatment of cholinergic urticaria with antiimmunoglobulin E therapy. Allergy 2008; 63:247-249.
-
(2008)
Allergy
, vol.63
, pp. 247-249
-
-
Metz, M.1
Bergmann, P.2
Zuberbier, T.3
Maurer, M.4
-
41
-
-
20044362008
-
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
-
DOI 10.1111/j.1398-9995.2004.00772.x
-
Humbert M, Beasley R, Ayres J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005; 60:309-316. (Pubitemid 40293346)
-
(2005)
Allergy: European Journal of Allergy and Clinical Immunology
, vol.60
, Issue.3
, pp. 309-316
-
-
Humbert, M.1
Beasley, R.2
Ayres, J.3
Slavin, R.4
Hebert, J.5
Bousquet, J.6
Beeh, K.-M.7
Ramos, S.8
Canonica, G.W.9
Hedgecock, S.10
Fox, H.11
Blogg, M.12
Surrey, K.13
-
42
-
-
34249799929
-
Predicting and evaluating response to omalizumab in patients with severe allergic asthma
-
DOI 10.1016/j.rmed.2007.01.011, PII S0954611107000388
-
Bousquet J, Rabe K, Humbert M, et al. Predicting and evaluating response to omalizumab in patients with severe allergic asthma. Respir Med 2007; 101:1483-1492. (Pubitemid 46850589)
-
(2007)
Respiratory Medicine
, vol.101
, Issue.7
, pp. 1483-1492
-
-
Bousquet, J.1
Rabe, K.2
Humbert, M.3
Chung, K.F.4
Berger, W.5
Fox, H.6
Ayre, G.7
Chen, H.8
Thomas, K.9
Blogg, M.10
Holgate, S.11
-
43
-
-
67649366101
-
The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
-
Holgate S, Buhl R, Bousquet J, et al. The use of omalizumab in the treatment of severe allergic asthma: a clinical experience update. Respir Med 2009; 103:1098-1113.
-
(2009)
Respir Med
, vol.103
, pp. 1098-1113
-
-
Holgate, S.1
Buhl, R.2
Bousquet, J.3
-
44
-
-
49549122199
-
Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis
-
Altrichter S, Kriehuber E, Moser J, et al. Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J Invest Dermatol 2008; 128:2232-2239.
-
(2008)
J Invest Dermatol
, vol.128
, pp. 2232-2239
-
-
Altrichter, S.1
Kriehuber, E.2
Moser, J.3
-
45
-
-
80051529993
-
IgE and IgG(4) autoantibodies against DFS70/LEDGF in atopic dermatitis
-
Watanabe K, Muro Y, Sugiura K, Tomita Y. IgE and IgG(4) autoantibodies against DFS70/LEDGF in atopic dermatitis. Autoimmunity 2011; 44:511-519.
-
(2011)
Autoimmunity
, vol.44
, pp. 511-519
-
-
Watanabe, K.1
Muro, Y.2
Sugiura, K.3
Tomita, Y.4
-
46
-
-
79960383879
-
FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid
-
Messingham KN, Srikantha R, DeGueme AM, Fairley JA. FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid. J Immunol 2011; 187:553-560.
-
(2011)
J Immunol
, vol.187
, pp. 553-560
-
-
Messingham, K.N.1
Srikantha, R.2
Degueme, A.M.3
Fairley, J.A.4
-
47
-
-
35748968191
-
Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels
-
DOI 10.1016/j.jaci.2007.08.060, PII S0091674907016612
-
Belloni B, Ziai M, Lim A, et al. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels. J Allergy Clin Immunol 2007; 120:1223-1225. (Pubitemid 350047479)
-
(2007)
Journal of Allergy and Clinical Immunology
, vol.120
, Issue.5
, pp. 1223-1225
-
-
Belloni, B.1
Ziai, M.2
Lim, A.3
Lemercier, B.4
Sbornik, M.5
Weidinger, S.6
Andres, C.7
Schnopp, C.8
Ring, J.9
Hein, R.10
Ollert, M.11
Mempel, M.12
-
48
-
-
61549086236
-
Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab
-
Fairley JA, Baum CL, Brandt DS, Messingham KA. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. J Allergy Clin Immunol 2009; 123:704-705.
-
(2009)
J Allergy Clin Immunol
, vol.123
, pp. 704-705
-
-
Fairley, J.A.1
Baum, C.L.2
Brandt, D.S.3
Messingham, K.A.4
|